Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Crabtree

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Nano Letters|March 30, 2005
Nanowires and nanoribbons of charge-density-wave conductor NbSe3Y S Hor, Z L Xiao, U Welp, et al.
Scientific Reports|October 13, 2016
Large spin-orbit coupling and helical spin textures in 2D heterostructure [Pb<sub>2</sub>BiS<sub>3</sub>][AuTe<sub>2</sub>]L Fang, J Im, W DeGottardi, et al.
Cancer Research|March 1, 1981
N,N-dimethylformamide and sodium butyrate modulation of the activities of purine-metabolizing enzymes in cultured human colon carcinoma cellsD L Dexter, G W Crabtree, J D Stoeckler, et al.
Nature|May 25, 2001
An unusual phase transition to a second liquid vortex phase in the superconductor YBa2Cu3O7F Bouquet, C Marcenat, E Steep, et al.
Biochemical Pharmacology|April 1, 1981
Activities of purine-metabolizing enzymes in human colon carcinoma cell lines and xenograft tumorsG W Crabtree, D L Dexter, J D Stoeckler, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-fluorouracilJ F Belliveau, M R Posner, G W Crabtree, et al.
Cancer Investigation|January 1, 1989
Site-selective cyclic AMP analogs as new biological tools in growth control, differentiation, and proto-oncogene regulationY S Cho-Chung, T Clair, P Tagliaferri, et al.
The Journal of Clinical Investigation|April 1, 1976
Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiencyR P Agarwal, G W Crabtree, R E Parks, et al.
Cancer Treatment Reports|October 1, 1986
Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretionJ F Belliveau, M R Posner, L Ferrari, et al.
Biochemical Pharmacology|July 15, 1982
Biochemical pharmacology and toxicology of 8-azaadenosine alone and in combination with 2'-deoxycoformycin (pentostatin)E N Spremulli, G W Crabtree, D L Dexter, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Nano Letters|March 30, 2005
Nanowires and nanoribbons of charge-density-wave conductor NbSe3Y S Hor, Z L Xiao, U Welp, et al.
Scientific Reports|October 13, 2016
Large spin-orbit coupling and helical spin textures in 2D heterostructure [Pb<sub>2</sub>BiS<sub>3</sub>][AuTe<sub>2</sub>]L Fang, J Im, W DeGottardi, et al.
Cancer Research|March 1, 1981
N,N-dimethylformamide and sodium butyrate modulation of the activities of purine-metabolizing enzymes in cultured human colon carcinoma cellsD L Dexter, G W Crabtree, J D Stoeckler, et al.
Nature|May 25, 2001
An unusual phase transition to a second liquid vortex phase in the superconductor YBa2Cu3O7F Bouquet, C Marcenat, E Steep, et al.
Biochemical Pharmacology|April 1, 1981
Activities of purine-metabolizing enzymes in human colon carcinoma cell lines and xenograft tumorsG W Crabtree, D L Dexter, J D Stoeckler, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-fluorouracilJ F Belliveau, M R Posner, G W Crabtree, et al.
Cancer Investigation|January 1, 1989
Site-selective cyclic AMP analogs as new biological tools in growth control, differentiation, and proto-oncogene regulationY S Cho-Chung, T Clair, P Tagliaferri, et al.
The Journal of Clinical Investigation|April 1, 1976
Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiencyR P Agarwal, G W Crabtree, R E Parks, et al.
Cancer Treatment Reports|October 1, 1986
Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretionJ F Belliveau, M R Posner, L Ferrari, et al.
Biochemical Pharmacology|July 15, 1982
Biochemical pharmacology and toxicology of 8-azaadenosine alone and in combination with 2'-deoxycoformycin (pentostatin)E N Spremulli, G W Crabtree, D L Dexter, et al.
Pageof 5